Category Archives: Oncology

Acentrus Specialty Providing NERLYNX® to Clients

Acentrus Specialty is a separate  Apexus offering. Apexus is a subsidiary of Vizient, the largest member-driven, health care performance improvement company in the country.

AON Specialty Pharmacy Impacting Community-Based Oncology Practices

AON Specialty Pharmacy, the in-house specialty pharmacy of the American Oncology Network, and Humana recently signed a new multi-year agreement that provides Humana members with in-network access to a range of pharmacy services. The AON Specialty Pharmacy works exclusively on behalf of more than 70 physicians in its growing network of community-based oncology practices across 11 […]

Jelmyto Poised for Successful Commercial Launch

UroGen has been preparing for the commercialization of Jelmyto by increasing customer awareness and discussing the high unmet need in low-grade UTUC

BMS Implementing Digital Therapeutics Strategy

BMS digital strategy has required thinking differently about the type of value-based relationships the company wants to establish

Oncology Biosimilars: Opportunity or Not?

Oncology Biosimilars: Opportunity or Not? VBCC – April 2016, Vol 7, No 3 – Employers’ Perspective F. Randy Vogenberg, PhD, RPh, Partner Access Market Intelligence Martha M. Rumore, PharmD, JD, MS, LLM, FAPhA The United States has the largest biologic drugs market and high prices for biologics, such as monoclonal antibodies, therapeutic proteins, immunomodulators, and […]

Big Data in Cancer Care: Limitations of Drug Claims

Big Data in Cancer Care: Limitations of Drug Claims VBCC – March 2016, Vol 7, No 2 – Employers’ Perspective Catherine E. Cooke, PharmD, BCPS F. Randy Vogenberg, PhD, RPh Partner, National Institute of Collaborative Healthcare, and Access Market Intelligence; Principal, Institute for Integrated Healthcare Greenville, SC As one part of an ongoing macrotheme regarding big […]